Loading organizations...
Loading organizations...
Developer of matrix regulator therapeutics for various diseases.
Symic Biomedical has raised $82.5M across 5 funding rounds.
Symic Biomedical has raised $82.5M in total across 5 funding rounds.
Symic Biomedical has raised $82.5M in total across 5 funding rounds.
Symic Biomedical's investors include Cell Innovation Partners, HEDA Ventures, Armen Shanafelt, National Institutes of Health, Ally Bridge Group, Claus Christiansen, InCube Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Purdue Research Foundation, QB3 Partners.
Symic Biomedical has raised $82.5M across 5 funding rounds. Most recently, it raised $11.0M Other Equity in April 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 26, 2019 | $11.0M Other Equity | Cell Innovation Partners | |
| May 22, 2017 | $30.0M Series B | HEDA Ventures | |
| Dec 1, 2015 | $25.0M Series A | Armen Shanafelt | |
| Aug 27, 2015 | $1.5M Grant | National Institutes of Health | |
| Jan 5, 2015 | $15.0M Series A | Armen Shanafelt | Ally Bridge Group, Claus Christiansen, InCube Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Purdue Research Foundation, QB3 Partners |